PCA3: Strong Clinical Validation

Progensa PCA3: Confirm negative biopsies with CONFIDENCE

• Accurately classify a “true negative” patient with a high negative predictive value of 90%.¹
• Men with a PCA3 Score of <25 are 4.58 times less likely to have a positive result on repeat biopsy than men with a score of 25 or greater.¹
• Large, independent NCI study confirms 90% NPV for men with low PCA3 score 

 

1. Gittleman, Marc C, et al. PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study. The Journal of Urology, Vol. 190, (2013): 64-69.
2. Wei, et al. Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer? Journal of Clinical Oncology. 11/2014; 32(36). 

 

Visit www.pca3.org

The Progensa^_® PCA3 assay is provided to Metamark by Hologic.